Lectin, Galactoside-Binding, Soluble, 9 (LGALS9) Peptid
LGALS9
Reaktivität: Säugetier
Wirt: Synthetic
BP, WB, IHC
-
- Target Alle Galectin 9 (LGALS9) Produkte
- Galectin 9 (LGALS9) (Lectin, Galactoside-Binding, Soluble, 9 (LGALS9))
- Protein-Typ
- Synthetic
- Spezies
- Säugetier
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequenz
- YPHPAYPMPF ITTILGGLYP SKSILLSGTV LPSAQRFHIN LCSGNHIAFH
- Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of LGALS9 antibody,
Alternative Names: LGALS9 control peptide, LGALS9 antibody Blocking Peptide, Anti-LGALS9 Blocking Peptide, Lectin Galactoside-Binding Soluble 9 Blocking Peptide, Galectin 9 Blocking Peptide, ECALECTIN Blocking Peptide, HUAT Blocking Peptide, MGC117375 Blocking Peptide, MGC125973 Blocking Peptide, MGC125974 Blocking Peptide, galectin-9 Blocking Peptide, LGALS9, LGALS-9, LGALS 9, LGALS-9 Blocking Peptide, LGALS 9 Blocking Peptide
-
-
- Applikationshinweise
- Optimal conditions should be determined by the investigator
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 °C long term.
-
- Target
- Galectin 9 (LGALS9) (Lectin, Galactoside-Binding, Soluble, 9 (LGALS9))
- Hintergrund
- The galectins are a family of beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. LGALS9 is an S-type lectin. It is overexpressed in Hodgkin's disease tissue and might participate in the interaction between the H&RS cells with their surrounding cells and might thus play a role in the pathogenesis of this disease and/or its associated immunodeficiency.
- Molekulargewicht
- 39 kDa
-
Sie sind hier:
